86 件中 1 - 20 件目
英語 ：Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y , New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan , Clinical and experimental nephrology, 26 (9) （909 - 916） , 2022 , （IF:2.801）
英語 ：Nagasu H, Yano Y, Kanegae H, Heerspink HJL, Nangaku M, Hirakawa Y, Sugawara Y, Nakagawa N, Tani Y, Wada J, Sugiyama H, Tsuruya K, Nakano T, Maruyama S, Wada T, Yamagata K, Narita I, Tamura K, Yanagita M, Terada Y, Shigematsu T, Sofue T, Ito T, Okada H, Nakashima N, Kataoka H, Ohe K, Okada M, Itano S, Nishiyama A, Kanda E, Ueki K, Kashihara N. , Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database , Diabetes Care, 44 (11) （2542 - 2551） , 2021 , （IF:19.112）
英語 ：Nakagawa N, Sofue T, Kanda E, Nagasu H, Matsushita K, Nangaku M, et al. , J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan , Scientific Reports, 10 （7351 - ） , 2020 , （IF:4.379）
英語 ：Nakagawa N, Sawada J, Sakamoto N, Takeuchi T, Takahashi F, Maruyama JI, Momosaki K, Nakamura K, Endo F, Hasebe N , High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations , Journal of Human Genetics, 64 (9) （891 - 898） , 2019 , （IF:3.545）
英語 ：Kitani Y, Nakagawa N, Sakamoto N, Takeuchi T, Takahashi F, Momosaki K, Nakamura K, Endo F, Maruyama H, Hasebe N , Unexpectedly High Prevalence of Coronary Spastic Angina in Patients With Anderson-Fabry Disease , Circulation Journal, 83 (2) （481 - 484） , 2019 , （IF:2.895）
英語 ：Nakagawa N, Kimura T, Sakate R, Isaka Y, Narita I , Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records , Clinical and experimental nephrology , 2023 , （IF:2.3）
英語 ：Suetsugu R, Sakuma H, Maruyama K, Matsuki M, Ogawa Y, Nakagawa N , Successful treatment of coexisting membranous nephropathy and immune thrombocytopenia by eradicating gastric Helicobacter pylori infection: a case report , Clinical and experimental nephrology case reports , 2023 , （IF:1.0）
英語 ：Nakagawa N , Fatty liver index has potential as a predictor of hypertension in the Japanese general population , Hypertension research, 46 (4) （896 - 897） , 2023 , （IF:5.525）
英語 ：Nakagawa N, Sato N. , Potential impact of non-dipping pulse rate pattern and nocturnal high pulse rate variability on target organ damage in patients with cardiovascular risk , Hypertension research, 46 (4) （1054 - 1055） , 2023 , （IF:5.573）
英語 ：Kanno T, Nakagawa N, Aonuma T, Kawabe JI, Yuhki KI, Takehara N, Hasebe N, Ushikubi F. , Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4 , Heart and Vessels, 38 (4) （606 - 613） , 2023 , （IF:1.814）
英語 ：Nasu M, Nakagawa N, Hara S, Yano J, Kurokawa Y, Nakamura N, Yokoyama H, Shimizu A, Sugiyama H, Sato H, Fukami K , A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry , Clinical and experimental nephrology, 27 (2) （141 - 150） , 2023 , （IF:2.617）
英語 ：Kario K, Hoshide S, Tomitani N, Nishizawa M, Yoshida T, Kabutoya T, Fujiwara T, Mizuno H, Narita K, Komori T, Ogata Y, Suzuki D, Ogoyama Y, Ono A, Yamagiwa K, Abe Y, Nakazato J, Nakagawa N, Katsuya T, Harada N, Kanegae H; HI–JAMP Study Group. , Inconsistent control status of office, home, and ambulatory blood pressure all taken using the same device: The HI-JAMP study baseline data , American journal of hypertension, 36 (2) （90 - 101） , 2023 , （IF:3.080）
英語 ：Mase K, Saito C, Usui J, Arimura Y, Nitta K, Wada T, Makino H, Muso E, Hirawa N, Kobayashi M, Yumura W, Fujimoto S, Nakagawa N, Ito T, Yuzawa Y, Matsuo S, Yamagata K , The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring , Clinical and experimental nephrology, 26 (11) （1092 - 1099） , 2022 , （IF:2.624）
英語 ：Nakagawa N, Nishio S , Knowledge of chronic kidney disease among the general population: A questionnaire survey in Hokkaido prefecture, Japan , Journal of Personalized Medicine, 12 (11) （1837 - ） , 2022 , （IF:3.508）
英語 ：Ikeuchi H, Sugiyama H, Sato H, Yokoyama H, Maruyama S, Mukoyama M, Hayashi H, Tsukamoto T, Fukuda M, Yamagata K, Ishikawa E, Uchida K, Kamijo Y, Nakagawa N, Tsuruya K, Nojima Y, Hiromura K , A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan , Clinical and experimental nephrology, 26 (9) （843 - 850） , 2022 , （IF:2.801）
英語 ：Nakagawa N , Prognostic value of target organ damage in patients with cardiovascular risks , Hypertension research , 2022 , （IF:3.872）
英語 ：Yamada N, Sakuma H, Yanai M, Suzuki A, Maruyama K, Matsuki M, Nakagawa N , Unexpectedly high renal pathological scores of two female siblings with Fabry disease presenting with urinary mulberry cells without microalbuminuria , Molecular Genetics and Metabolism Reports, 31 （100874 - ） , 2022 , （IF:2.797）
英語 ：Morishita Y, Nakagawa N , Influence of Nutrients on Kidney Diseases , Nutrients, 14 (6) （1234 - ） , 2022 , （IF:5.719）
英語 ：Nakagawa N , Seasonal variation and predictors of intradialytic hypotension , Hypertension research, 44 (11) （1551 - 1553） , 2021 , （IF:3.872）
英語 ：Nakagawa N, Maruyama K, Hasebe N , Utility of Geriatric Nutritional Risk Index in Patients with Chronic Kidney Disease: A Mini-Review , Nutrients, 13 (11) （3688 - ） , 2021 , （IF:5.719）
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.